On this page
PLP1
proteolipid protein 1
PLP1 is located on the long (q) arm of chromosome X, at band Xq22.2. Arm ratio per GRCh38 - banding schematic.
Explore chromosome X in the library →Available at Jeen Health
Clinical tests that include this
Overview
PLP1 is located on the X chromosome and encodes proteolipid protein 1, one of the most abundant proteins in the central nervous system myelin. Myelin is the fatty protective layer that wraps around nerve fibres, enabling rapid electrical signal transmission between nerve cells. The gene produces two protein isoforms through alternative splicing: proteolipid protein 1, which is expressed predominantly in the brain and spinal cord, and DM20, which is found mainly in peripheral nerves connecting the central nervous system to muscles.
Because PLP1 follows X-linked inheritance, pathogenic variants typically cause more severe symptoms in males, who have only one X chromosome. Females who carry a single pathogenic variant are generally less affected or may show no symptoms. Variants in this gene disrupt myelin formation and maintenance, leading to progressive neurological conditions that impair movement, coordination, and cognitive development.
What the gene does
Proteolipid protein 1 and DM20 are embedded within the cell membranes of oligodendrocytes, the specialised cells responsible for producing myelin in the central nervous system. These proteins help anchor myelin to the oligodendrocyte membrane, maintaining the structural integrity of the myelin sheath. Together, they account for a large fraction of total myelin protein content, reflecting their critical role in insulation function.
The two isoforms differ slightly in structure, with DM20 lacking a 35-amino-acid segment present in the full-length proteolipid protein 1. This difference influences where each isoform is predominantly expressed and may affect their specific roles in myelin assembly and stability. Both isoforms are hydrophobic proteins that span the membrane multiple times, forming a compact structure that contributes to the tight wrapping of myelin around axons. Proper function of these proteins is essential for the rapid transmission of nerve impulses and for preventing signal loss along nerve fibres.
Video: Genetics 101
Chromosome location
PLP1 is located at Xq22.2 on the long arm of the X chromosome. The gene spans approximately 17 kilobases of genomic DNA and contains seven exons. Its position on the X chromosome determines the X-linked inheritance pattern observed in associated conditions, whereby males are typically more severely affected than females.
Protein structure
Domain architecture has not been experimentally characterised in detail for this protein. Proteolipid protein 1 is a 277-amino-acid hydrophobic protein with multiple transmembrane segments that allow it to integrate tightly into lipid membranes. The DM20 isoform is generated by alternative splicing that removes 35 amino acids from the cytoplasmic loop region, resulting in a slightly smaller protein that retains the core membrane-spanning structure.
Key variants
Hundreds of pathogenic variants in PLP1 have been documented, including missense changes, deletions, duplications, and splicing alterations. The spectrum of variants correlates with a range of clinical severity, from severe early-onset forms of Pelizaeus-Merzbacher disease to milder presentations such as spastic paraplegia type 2. Gene duplications are among the most common causes of Pelizaeus-Merzbacher disease, while point variants often result in milder phenotypes.
No pathogenic or likely-pathogenic ClinVar variants recorded yet for this gene.
Associated conditions
Pathogenic variants in PLP1 cause a spectrum of neurological conditions that primarily affect myelin formation and nerve function. Pelizaeus-Merzbacher disease is the most recognised associated condition, characterised by abnormal eye movements, developmental delays, movement abnormalities, and progressive deterioration of motor skills. The condition predominantly affects males and typically presents in infancy or early childhood.
Spastic paraplegia type 2 is another condition linked to PLP1 variants, generally presenting later and causing progressive muscle stiffness and weakness in the lower limbs. This form of hereditary spastic paraplegia is milder than Pelizaeus-Merzbacher disease and may not become apparent until adolescence or adulthood. Both conditions reflect the essential role of proteolipid protein 1 in maintaining healthy myelin throughout life.
- Pelizaeus-Merzbacher disease Dedicated page coming soon
Inheritance pattern
Conditions caused by pathogenic PLP1 variants typically follow x-linked inheritance.
X-linked recessive: sons of a carrier mother have a 50% chance of being affected. Daughters have a 50% chance of being carriers.
UK clinical status
PLP1 is included on multiple NHS Genomic Medicine Service gene panels, reflecting its established clinical significance in diagnosing inherited neurological disorders. The gene holds green classification on panels including Intellectual Disability (R29), Inherited White Matter Disorders, Adult Onset Hereditary Spastic Paraplegia (R60), Childhood Onset Hereditary Spastic Paraplegia (R61), and Adult Onset Leukodystrophy (R62). Green classification indicates strong evidence supporting the gene's role in these conditions, making PLP1 testing part of standard diagnostic pathways for patients presenting with relevant clinical features in the UK.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
Why does PLP1 primarily affect males?
PLP1 is located on the X chromosome, following X-linked inheritance. Males have only one X chromosome, so a single pathogenic variant will cause disease. Females have two X chromosomes, so typically one functional copy can partially compensate, resulting in milder symptoms or no symptoms at all.
What is the difference between Pelizaeus-Merzbacher disease and spastic paraplegia type 2?
Both conditions result from PLP1 variants but differ in severity and presentation. Pelizaeus-Merzbacher disease is more severe, typically presenting in infancy with widespread neurological symptoms including abnormal eye movements and developmental delays. Spastic paraplegia type 2 is milder, often appearing later in life with progressive stiffness and weakness mainly affecting the legs.
Can females who carry a PLP1 variant have symptoms?
Yes, some female carriers may experience mild symptoms, though this is less common than in males. The pattern and severity of symptoms in carrier females can vary depending on X-chromosome inactivation, the random process by which one X chromosome is silenced in each cell.